Valeo Financial Advisors, LLC Veracyte, Inc. Transaction History

Valeo Financial Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$32.94 - $56.62 $16,371 - $28,140	-497 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$44.47 - $81.38 $8,805 - $16,113	-198 Reduced 28.49%	497 $27,000
Q4 2020 Feb 11, 2021	BUY	$32.49 - $61.88 $3,249 - $6,188	100 Added 16.81%	695 $34,000
Q3 2020 Oct 28, 2020	SELL	$26.73 - $35.67 $1,603 - $2,140	-60 Reduced 9.16%	595 $19,000
Q2 2020 Jul 20, 2020	SELL	$19.49 - $28.11 $7,795 - $11,244	-400 Reduced 37.91%	655 $17,000
Q1 2020 Apr 13, 2020	BUY	$16.13 - $30.17 $4,693 - $8,779	291 Added 38.09%	1,055 $155,000
Q4 2019 Jan 24, 2020	BUY	$20.78 - $29.99 $10,390 - $14,995	500 Added 189.39%	764 $21,000
Q2 2019 Jul 10, 2019	SELL	$22.1 - $28.56 $176 - $228	-8 Reduced 2.94%	264 $8,000
Q1 2019 Apr 12, 2019	BUY	$12.0 - $25.76 $3,264 - $7,006	272 New	272 $7,000

307

81.7M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.8B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.